MNKD Q3 2021 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+44.7% YoY

Gross Profit

$12M55.5% margin

Operating Income

-$7M-29.7% margin

Net Income

-$4M-19.9% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

-4.6%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$19M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$238M

Total Liabilities

$423M

Stockholders' Equity

-$185M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$15M	+44.7%
Gross Profit	$12M	$10M	+21.1%
Operating Income	-$7M	-$9M	+27.8%
Net Income	-$4M	-$11M	+60.7%

Revenue Segments

Product

$10M62%

License And Service

$6M38%